TipRanks

Notifications

Tag: ACLX

Total 153 Posts

Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Adaptive Biotechnologies (ADPT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcellx Inc (ACLXResearch Report) and Adaptive Biotechnologies (ADPTResearch Report) with bullish sentiments.

Arcellx Inc (ACLX)

Scotiabank analyst George Farmer maintained a Buy rating on Arcellx Inc today and set a price target of $82.00. The company’s shares closed last Wednesday at $63.20.

According to TipRanks.com, Farmer is a 5-star analyst with an average return of 20.8% and a 58.9% success rate. Farmer covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, BioMarin Pharmaceutical, and Syndax Pharmaceuticals.

Currently, the analyst consensus on Arcellx Inc is a Strong Buy with an average price target of $79.70.

See Insiders’ Hot Stocks on TipRanks >>

Adaptive Biotechnologies (ADPT)

In a report released today, Sung Ji Nam from Scotiabank maintained a Buy rating on Adaptive Biotechnologies, with a price target of $10.00. The company’s shares closed last Wednesday at $2.68, close to its 52-week low of $2.61.

According to TipRanks.com, Nam has 0 stars on 0-5 stars ranking scale with an average return of -4.7% and a 43.5% success rate. Nam covers the Healthcare sector, focusing on stocks such as Pacific Biosciences, Castle Biosciences, and Twist Bioscience.

Currently, the analyst consensus on Adaptive Biotechnologies is a Moderate Buy with an average price target of $6.60, representing a 123.0% upside. In a report issued on April 2, J.P. Morgan also maintained a Buy rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ACLX: